中医药学报
中醫藥學報
중의약학보
ACTA CHINESE MEDICINE AND PHARMACOLOGY
2014年
3期
79-82
,共4页
叶利群%楼凯凌%陈嫣%蒋婴
葉利群%樓凱凌%陳嫣%蔣嬰
협리군%루개릉%진언%장영
高危人类乳头瘤病毒%中药%扶正解毒法%临床疗效%血清IL-6
高危人類乳頭瘤病毒%中藥%扶正解毒法%臨床療效%血清IL-6
고위인류유두류병독%중약%부정해독법%림상료효%혈청IL-6
Cervical high-risk human papilloma virus ( HR-HPV)%Chinese medicine%Fuzheng Jiedu therapy%Clinical effect%Serum IL-6
目的:观察扶正解毒法干预宫颈高危型人乳头瘤病毒(简称HR-HPV)感染的临床疗效及患者体内血清IL-6的变化,探讨扶正解毒法干预宫颈HR-HPV感染的临床价值及作用机制。方法:将宫颈高危型人乳头状病毒感染患者120例随机分成中药联合组(口服扶正解毒汤联合外用清毒散),单纯中药上药组和西药上药组(α-干扰素),比较三组治疗前后症状、体征积分,HR-HPV病毒载量及血清IL-6的变化。结果:治疗后中药联合组分别与对照组中药上药组、西药上药组比较,症状、体征积分下降更明显,说明中药联合组能明显改善患者症状、体征评分,且优于对照组;治疗后中药联合组与对照组中药上药组、西药上药组比较,病毒载量下降更快,差异有统计学意义(P<0.05)。说明中药联合组能显著降低HPV载量值,且明显优于对照组中药上药组和西药上药组;三组治疗前血清IL-6差异无统计学意义(P>0.05),治疗后中药联合组血清IL-6下降明显,而中药上药组和西药上药组无明显变化,差异有统计学意义(P<0.05)。结论:中药扶正解毒法能有效治疗宫颈高危型人乳头状病毒感染,提高机体免疫功能,阻断宫颈疾病进展。
目的:觀察扶正解毒法榦預宮頸高危型人乳頭瘤病毒(簡稱HR-HPV)感染的臨床療效及患者體內血清IL-6的變化,探討扶正解毒法榦預宮頸HR-HPV感染的臨床價值及作用機製。方法:將宮頸高危型人乳頭狀病毒感染患者120例隨機分成中藥聯閤組(口服扶正解毒湯聯閤外用清毒散),單純中藥上藥組和西藥上藥組(α-榦擾素),比較三組治療前後癥狀、體徵積分,HR-HPV病毒載量及血清IL-6的變化。結果:治療後中藥聯閤組分彆與對照組中藥上藥組、西藥上藥組比較,癥狀、體徵積分下降更明顯,說明中藥聯閤組能明顯改善患者癥狀、體徵評分,且優于對照組;治療後中藥聯閤組與對照組中藥上藥組、西藥上藥組比較,病毒載量下降更快,差異有統計學意義(P<0.05)。說明中藥聯閤組能顯著降低HPV載量值,且明顯優于對照組中藥上藥組和西藥上藥組;三組治療前血清IL-6差異無統計學意義(P>0.05),治療後中藥聯閤組血清IL-6下降明顯,而中藥上藥組和西藥上藥組無明顯變化,差異有統計學意義(P<0.05)。結論:中藥扶正解毒法能有效治療宮頸高危型人乳頭狀病毒感染,提高機體免疫功能,阻斷宮頸疾病進展。
목적:관찰부정해독법간예궁경고위형인유두류병독(간칭HR-HPV)감염적림상료효급환자체내혈청IL-6적변화,탐토부정해독법간예궁경HR-HPV감염적림상개치급작용궤제。방법:장궁경고위형인유두상병독감염환자120례수궤분성중약연합조(구복부정해독탕연합외용청독산),단순중약상약조화서약상약조(α-간우소),비교삼조치료전후증상、체정적분,HR-HPV병독재량급혈청IL-6적변화。결과:치료후중약연합조분별여대조조중약상약조、서약상약조비교,증상、체정적분하강경명현,설명중약연합조능명현개선환자증상、체정평분,차우우대조조;치료후중약연합조여대조조중약상약조、서약상약조비교,병독재량하강경쾌,차이유통계학의의(P<0.05)。설명중약연합조능현저강저HPV재량치,차명현우우대조조중약상약조화서약상약조;삼조치료전혈청IL-6차이무통계학의의(P>0.05),치료후중약연합조혈청IL-6하강명현,이중약상약조화서약상약조무명현변화,차이유통계학의의(P<0.05)。결론:중약부정해독법능유효치료궁경고위형인유두상병독감염,제고궤체면역공능,조단궁경질병진전。
Objective: To study Fuzheng Jiedu therapy in the treatment of cervical high -risk human papilloma virus (HR-HPV) infection and changes of serum IL -6.Discuss the clinical value and action mechanism of Fuzheng Jiedu therapy in the treatment of cervical HR -HPV.Methods:According to the random method ,120 cases of cervical HR-HPV infection patients were divided into three groups : Chinese Medication combination group ( taking orally with Fuzheng Jiedu soup and external use of Xiaodu powder ) , Chinese medication external use group , western medication (interferon-alpha) external use group.Change of the symptom,the score of symptom,the viral loads of HR-HPV,the serum IL-6 were compared among three groups .Results: After treatment , the Chinese medication combination group had an obviously better effect than other two control groups ,the Chinese medication combination group ’ s viral loads of HR-HPV declined faster than those in other two control goups , and there was a significant difference among three groups ( P<0 .05 ) .Before treatment , the serum IL-6 value of the three groups had no significantly statistical difference (P>0.05).After treatment, the Chinese medication combination group’s serum IL-6 value decreased significantly, the serum IL-6 value of other two control groups had no obvious change ,and there was a significant difference among three groups ( P<0 .05 ) .Conclusion:Fuzheng Jiedu therapy has an obvious effect in the treatment of cervical high -risk human papilloma virus(HR-HPV),and can improve the immune function of organism and block the progress of the cervical virus.